Nicola Bedlington

Speaker

Valuing Patient Involvement - A European Perspective

More about

Dr. Bruno Strigini

Speaker

Research Based Pharma Companies in Austerity Times

More about

Dr. Greet Musch

Speaker

General Director for the DG Pre-authorisation

More about

Richard Bergström

Chair

Director General of EFPIA

More about

Dr. Alexandra Wyke

Speaker

Belgium’s Patient Movement: Size and Scope

More about

Geert Noels

Speaker

The Pharma Sector after the Econoshock

More about

Ingrid Maes

Speaker

The Strategic Plan to Promote Clinical Trials in Belgium

More about

Dr. Stefaan Vancayzeele

Chair

Dr. Stefaan Vancayzeele, MD, is CSO (Chief Scientific Officer) at Novartis Belgium, Vice-President of BeAPP and Secretary of BCPM

More about

Tom Heyman

Chair

CEO of Janssen Pharmaceutica N.V. in Belgium

More about

Prof. Dr. Leo Neels

Chair

CEO of pharma.be

More about

David Bouchez

Speaker

Clinical Trials with Medical Devices

More about

Prof. Dr. André Scheen

Speaker

Clinical inertia, a major concern in drug therapy

More about

Dr. Ri
De Ridder

Speaker

Unmet medical need and early access

More about

DR. MAIKEL
RAGHOEBAR

Speaker / Chair

Senior Director, Head Clinical Pharmacology Unit of Janssen in Belgium

More about

PROF. DR.
JAN DE HOON

Speaker

Biomarkers: what’s in a name?

More about

magali geens

Speaker

Patient involvement: a new challenge for the industry

More about

Dr. Markus Breuer

Speaker

Head of Education at the Institute Dialogue Ethics –Interdisciplinary Institute for ethics in health care in Zurich (CH)

More about

Dr. Jo De Cock

Chair

General administrator National Institute of Health & Disability Insurance (RIZIV)

More about

the belgian
pharmaceutical
conference

  • New, interactive concept under the umbrella theme
    ”The Impatient Patient ©”

  • Unprecedent networking event with all healthcare partners (multi-stakeholder forum)

  • Top notch speakers
    with international and national expertise

Organizers
and Partners
Why Attend

Illu Vid

BeAPP and pharma.be

Illu Vid

Novartis,
Novellas Healthcare and
Price Waterhouse Coopers

Click on the image above to view the insight video presenting the 2012 edition of the Belgian pharmaceutical conference